Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-20 · accession 0001162194-21-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-24 | 2021-11-20 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | F - Tax | $4.49 | -2,014 | 79.2K | -2% | -$9,043 |
| D | 2021-11-24 | 2021-11-20 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | M - OptEx | $0.00 | +4,063 | 81.2K | +5% | $0 |
| D | 2021-11-24 | 2021-11-20 | LAB | Khadder Nicholas | SVP, Gen. Counsel, Sec | M - OptEx | $0.00 | -4,063 | 40.6K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-20 | F | D | 2,014 | $4.49 | 79,235 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-20 | M | A | 4,063 | $0.00 | 81,249 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-11-20 | M | D | 4,063 | $0.00 | 40,625 | D | — · — to — | 4,063 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. (F2) On May 23, 2020, the Reporting Person was granted 65,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. |